The only available score to assess the risk for fatal bleeding in patients with venous thromboembolism (VTE) has not been validated yet. We used the RIETE database to validate the risk-score for fatal bleeding within the first 3 months of anticoagulation in a new cohort of patients recruited after the end of the former study.
Accuracy was measured using the ROC curve analysis. The accuracy of the score in this validation cohort was similar to the accuracy found in the index study.
Interestingly, it performed better for predicting gastrointestinal than intracranial fatal bleeding.